Sacral Nerve Stimulation Clinical Trials

Clinical trials related to Sacral Nerve Stimulation Procedure

Feasibility and Safety Study to Evaluate the Sensing and Stimulation Performance of a Personalised Sacral Neuromodulation (SNM) System for Refractory Overactive Bladder

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn whether a new sacral neuromodulation (SNM) system (INO-SNM-01) can safely and effectively sense bladder nerve activity and provide stimulation to help manage symptoms of refractory overactive bladder in adult women aged 18-70 who have not responded to standard treatments. The main questions it aims to answer are: * Is there a clear relationship between bladder nerve activity and patient-reported urgency sensations? * Can targeted stimulation based on bladder nerve activity reduce overactive bladder symptoms? * Is the INO-SNM-01 System safe to use? Researchers will not use a comparison group in this study. Instead, all participants will receive the investigational device to see if it works as intended. Participants will undergo surgery to have a temporary trial lead implanted near the sacral nerve and spend up to 2 days in hospital for monitoring and testing to assess the device sensing and stimulation capabilities. Up to 10 participants will take part in this first-in-human feasibility study at a single site in Australia.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• Adult female participants between 18 and 70 years of age

• Diagnosed with refractory overactive bladder that is resistant to behavioural therapy and/or pharmacotherapy, for at least 12 weeks

• Experience at least 3 urgency episodes within a 24-hour period from the past 3 consecutive days (reported in a bladder diary)

• Baseline of greater than 7 on the Overactive Bladder Symptom Score (OABSS)

• Baseline score of greater than 12 on the International Consultation on Incontinence Questionnaire Female Lower Urinary Tract Symptoms Modules (ICIQ-FLUTS)

• Willing to receive SNM therapy

• Willing to provide free and Informed consent to participate in the clinical investigation

• Able to understand all study instructions, willing to attend all study visits, and likely to comply with all study procedures

Locations
Other Locations
Australia
St George Private Hospital
RECRUITING
Kogarah
St George Urology
RECRUITING
Kogarah
Contact Information
Primary
Christopher Ong
chris.ong@wonderlandmedical.com
+61411256603
Time Frame
Start Date: 2026-02-27
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 10
Treatments
Experimental: INOPASE Sacral Neuromodulation System 01 (INO-SNM-01)
Participants are implanted with the Trial Lead and undergo 2 days of monitoring in hospital with the INO-SNM-01 System.
Sponsors
Leads: INOPASE Pty Ltd

This content was sourced from clinicaltrials.gov